CD274 and hepatocellular carcinoma: Then, we reintroduced the recombinant GOLM1 that was not sensitive to shRNA (shRES-GOLM1) into the GOLM1-KD cells and found that the re-expression of GOLM1 rescues the decreased PD-L1 expression in GOLM1-KD HCC cells, thereby excluding the possibility of off-target effects.